FDA Updates Warning About Antidepressant Pristiq
The U.S. Food and Drug Administration has updated a warning about the antidepressant Pristiq (desvenlafaxine succinate) that it can lead to serotonin syndrome, a potentially life-threatening condition. The risk of suicidal thoughts and behaviors in pediatric and young adult patients is increased when used with other drugs that impair metabolism of serotonin.
The FDA has more information.